Zenith® Dissection Clinical Trial
The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of acute, complicate Type B aortic dissection.
|Study Design:||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Use of the Zenith® Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissection|
- Freedom from major adverse events and survival [ Time Frame: 30 days ] [ Designated as safety issue: Yes ]
|Study Start Date:||August 2012|
|Estimated Study Completion Date:||June 2019|
|Estimated Primary Completion Date:||November 2015 (Final data collection date for primary outcome measure)|
Device: Endovascular Treatment (Zenith)
Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01568320
|Contact: Amy Griggsfirstname.lastname@example.org|
Show 30 Study Locations
|Principal Investigator:||Joseph Lombardi, MD||The Cooper Health System|